Research Aims and Achievements

Pirogov Medical University is a leading Russian medical and biomedical research and innovation center. Our scientific activity is aimed primarily at practical health care and at the same time at obtaining new knowledge about the mechanisms of human diseases.

We actively cooperate with scientific institutes of Russian Academy of Science, as well as research and clinical centers, and biotechnological and pharmaceutical companies around the world.

Main areas of research includes oncology, neurobiology, allergies and immunology, medical genetics, regenerative medicine, medical microbiology and infectious diseases.

The University takes an active part in conducting clinical and preclinical studies of new drugs, biomedical cell products and medical devices.

We are developing our own scientific journal, which accepts articles on clinical medicine and biomedical sciences. The journal is published in Russian and English and is included in the Scopus and WoS.

We pay great attention to the early involvement of our students in research. The University’s Student Scientific Society unites more than 80 scientific groups working on various topics in the field of therapy, pediatrics, surgery, and biomedicine. Students receive not only additional clinical practice, but learn to observe, conduct research and formulate their results in accordance with accepted practice. Graduates can continue their career in science at the University PhD School.

Scientific and practical conferences organized by the University for reseachers as well as for students and young scientists create a convenient platform for presenting new research and exchange of experience. Meetings with leading scientists of the world, constantly organized by the University, allow them to keep abreast of the latest achievements of biomedicine and medicine.

Last Research News

The University’s Scientific Clinical Institute of Pediatrics was one of the first in Russia where gene therapy with Zolgensma was given to children with spinal muscular atrophy

In April 2020, for the first time, gene therapy of patients with spinal muscular atrophy (SMA) was carried out on the territory of the Russian Federation using the drug AVXS-101 (registered in the USA as Zolgensma®). This means that in our country for...
Read more

December 19, 2019. Lecture by Professor Sebastian Kotofan

The lecture by the Sebastian Kotofan, professor of the Clinical Medical and Scientific College of Mayo (USA), on the topic "Recent Modern Discoveries about the Anatomy of the Face" was held in auditorium A1 of our University. The lecture was attended by...
Read more

II All-Russian Conference “Rehabilitation Based on Neurotechnologies”

On December 13, the second scientific All-Russian conference “Rehabilitation based on neurotechnologies” dedicated to the research of rehabilitation equipment, which works on the basis of the brain-computer interface, took place in our University. “Today...
Read more

Partnership agreement between University Innovative Company "Exoplast" and Shvabe holding

November 18 at the Medica exhibition in Dusseldorf (Germany) a innovative enterprise of the University "Exoplast" and the holding "Schwabe" of the State Corporation Rostec signed an Agreement on cooperation in Western Europe. Exoplast is the developer...
Read more